Chemomab Therapeutics (CMMB) Operating Leases (2019 - 2025)
Chemomab Therapeutics (CMMB) posted Operating Leases of $179000.0 for Q1 2025, down 44.75% on a QoQ basis from $324000.0 in Q4 2024, and down 36.07% year-over-year from $280000.0 in Q1 2024.
Chemomab Therapeutics (CMMB) Operating Leases (2019 - 2025) Analysis & Trends
Chemomab Therapeutics' Operating Leases history runs 7 years deep, the most recent figure standing at $179000.0 for Q1 2025.
- Quarterly Operating Leases fell 36.07% year-over-year to $179000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $179000.0 (down 36.07% YoY) and the FY2024 annual result came in at $324000.0, down 17.35% from the prior year.
- Operating Leases was $179000.0 for Q1 2025 at Chemomab Therapeutics, down from $324000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $392000.0 in Q4 2023 and bottomed at $5000.0 in Q3 2023.
- A 5-year average of $212058.8 and a median of $230000.0 in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases sank 95.76% — and 2024, when it jumped 4500.0%.
- Chemomab Therapeutics' Operating Leases stood at $343000.0 in 2021, then sank by 73.47% to $91000.0 in 2022, then surged by 330.77% to $392000.0 in 2023, then fell by 17.35% to $324000.0 in 2024, then plunged by 44.75% to $179000.0 in 2025.
- Business Quant data shows CMMB's Operating Leases at $179000.0 in Q1 2025, $324000.0 in Q4 2024, and $230000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 179,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 251,000.00 |
| Mar 31, 2024 | 280,000.00 |
| Dec 31, 2023 | 392,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 91,000.00 |
| Sep 30, 2022 | 118,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 203,000.00 |
| Dec 31, 2021 | 343,000.00 |
| Sep 30, 2021 | 298,000.00 |
| Jun 30, 2021 | 320,000.00 |
| Mar 31, 2021 | 328,000.00 |
| Dec 31, 2020 | 358,000.00 |
| Sep 30, 2020 | 63,000.00 |
| Jun 30, 2020 | 108,000.00 |